PO.TB04.03 · 肿瘤生物学
在微生理系统中量化抗肿瘤和促肿瘤人中性粒细胞对自然杀伤细胞行为的双重效应
Quantifying the dual effect of anti-tumor and pro-tumor human neutrophils on natural killer cell behaviors in a microphysiological system
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
中性粒细胞可通过抑制自然杀伤(NK)细胞的抗肿瘤活性来促进肿瘤进展,NK细胞被认为是抵御癌症的第一道防线。小鼠研究显示,中性粒细胞可被极化为抗肿瘤的"N1"状态或促肿瘤的"N2"状态。然而,N1和N2中性粒细胞亚型在人类癌症中如何以不同方式影响NK细胞行为尚不清楚。在人类肿瘤组织中监测中性粒细胞-NK细胞相互作用也具有挑战性。在此,我们构建了一个基于人细胞的微生理系统,以测量N1和N2中性粒细胞亚型对NK细胞迁移、运动、肿瘤细胞毒性和肿瘤浸润的不同影响。我们使用标准光刻技术制作了三通道微流控芯片。为模拟NK细胞向不同中性粒细胞亚型的优先迁移(情景1),微流控芯片的两个侧通道分别接种经LPS、IFN-gamma和IFN-beta极化的N1中性粒细胞和经TGF-beta极化的N2 HL-60中性粒细胞,中央通道接种NK-92MI细胞。为模拟NK细胞对肿瘤的细胞毒性(情景2),侧通道接种NK-92MI细胞、PANC-1胰腺肿瘤球体和N1或N2中性粒细胞的混合物。所有细胞均包埋在3D胶原水凝胶中以模拟胰腺肿瘤组织的细胞外基质。进行延时成像和终点共聚焦成像,以捕捉情景1中的NK细胞迁移和运动以及情景2中的肿瘤球体凋亡和NK细胞-肿瘤浸润。在24小时内,NK-92MI细胞向N1中性粒细胞迁移的百分比(在t=24 h时为12.07% vs. 5.11%,p<0.001)和最大迁移率(1.31 vs. 0.73%/h,p<0.01)均高于向N2中性粒细胞的迁移。NK-92MI细胞迁移至N2中性粒细胞后的运动能力高于迁移至N1中性粒细胞,表现在速度(在t=12 h时为1.07 vs. 0.80 μm/min)、位移(在t=12 h时为9.89 vs. 6.89 μm)和方向性(在t=24 h时为0.43 vs. 0.36)方面(p<0.0001)。因此,NK-92MI细胞表现出向N1相对于N2中性粒细胞的优先迁移,尽管其迁移至N1后相比迁移至N2中性粒细胞速度减慢。此外,N1中性粒细胞恢复了NK细胞对肿瘤球体的细胞毒性(0.97 vs. 1.01,p>0.99),而N2中性粒细胞则抑制了它(0.97 vs. 0.54,p<0.0001),尽管N1和N2中性粒细胞均抑制了NK细胞对肿瘤球体的浸润(对照 vs. N1 vs. N2:8.04 vs. 5.87 vs. 5.49%,p<0.01)。我们还发现,N1中性粒细胞分泌的NK细胞趋化因子IP-10水平较高,并诱导NK-92MI细胞表达比N2中性粒细胞更高水平的活化标志物CD107a和IFN-gamma。这项研究揭示了人中性粒细胞在调节NK细胞行为中的双重作用以及复杂的中性粒细胞-NK细胞串扰,提示重编程中性粒细胞以逆转对NK细胞的免疫抑制可能是一种潜在的癌症治疗策略。
查看英文原文 English abstract
Neutrophils can promote tumor progression by inhibiting the antitumor activity of natural killer (NK) cells known as the first line of defense against cancer. Studies in mice show that neutrophils can be polarized toward either an anti-tumor “N1” or a pro-tumor “N2” state. However, it is unknown how N1 and N2 neutrophil subtypes influence NK cell behaviors differently in human cancer. It is also challenging to monitor neutrophil-NK cell interactions in the human tumor tissue. Here, we engineered a human cell-based microphysiological system to measure the distinct effect of N1 and N2 neutrophil subtypes on NK cell migration, motility, tumor cytotoxicity, and tumor infiltration. We fabricated a three-channel microfluidic chip using standard lithography. To model the preferential migration of NK cells toward different neutrophil subtypes (scenario 1), the two side channels of the microfluidic chip were seeded with LPS, IFN-gamma, and IFN-beta-polarized N1 and TGF-beta-polarized N2 HL-60 neutrophils respectively and the central channel was seeded with NK-92MI cells. To model NK cell cytotoxicity against tumor (scenario 2), the side channels were seeded with a mixture of NK-92MI cells, PANC-1 pancreatic tumor spheroids, and N1 or N2 neutrophils. All cells were embedded in 3D collagen hydrogel to mimic the extracellular matrix of the pancreatic tumor tissue. Time-lapse imaging and end-point confocal imaging were performed to capture NK cell migration and motility in scenario 1 and tumor spheroid apoptosis and NK cell-tumor infiltration in scenario 2. NK-92MI cells showed both a higher percentage of migration (12.07 vs. 5.11% at t=24 h, p<0.001) and a higher maximum rate of migration (1.31 vs. 0.73%/h, p<0.01) to N1 neutrophils than to N2 neutrophils over 24 h. NK-92MI cells showed a higher motility after migration to N2 neutrophils than N1 neutrophils in speed (1.07 vs. 0.80 µm/min at t=12 h), displacement (9.89 vs. 6.89 µm at t=12 h), and directionality (0.43 vs. 0.36 at t=24 h) (p< 0.0001). Hence, NK-92MI cells showed preferential migration to N1 over N2 neutrophils, although they slowed down after migration to N1 compared to N2 neutrophils. Moreover, N1 neutrophils restored NK cell cytotoxicity against tumor spheroids (0.97 vs. 1.01, p>0.99) while N2 neutrophils suppressed it (0.97 vs. 0.54, p<0.0001), although both N1 and N2 neutrophils inhibited NK cell infiltration in tumor spheroids (control vs. N1 vs. N2: 8.04 vs. 5.87 vs. 5.49%, p<0.01). We also found that N1 neutrophils secreted a higher level of NK cell chemokine IP-10 and induced higher expressions of activation markers CD107a and IFN-gamma by NK-92MI cells than N2 neutrophils. This study reveals the dual role of human neutrophils in modulating NK cell behaviors and the complex neutrophil-NK cell crosstalk, suggesting reprogramming neutrophils to reverse the immunosuppression on NK cells as a potential therapeutic strategy for cancer.
利益披露 Disclosure
S. Shao, None..
C. N. Jones, None.